Enhanced transparency and exchange of information to put an end to bank secrecy and fight tax evasion and avoidance ...

BIOSeedin Innovation Partnering Conference solidified its role as a nexus for global biopharma innovation, attracting more than 2,000 registrants from 10 countries. Senior executives and investors ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

ROCKVILLE, Md. - GlycoMimetics, Inc. (NASDAQ:GLYC), a clinical-stage biotechnology company currently trading at $0.20 per share with a market capitalization of approximately $13 million, announced ...

But the risk goes much deeper. Apple hasn't ramped up enough on data centers, which means the company doesn't have the infrastructure support required to internally run an AI ecosystem like its ...

I see an upside to the current valuation for Fast Retailing, following the stock's lackluster performance YTD, despite the company posting solid earnings and a full-year outlook. The company has ...

His case study on a Claudin 18.2-targeted therapy—now in global Phase III—highlighted China's evolving role from fast follower to protocol co-designer.

The competition in Europe is fast-paced, and there needs to be quick ... competitors can establish quickly within a customer-and-innovator-friendly marketplace. European emerging markets are ...

"Our reference architecture with AMD provides a fast, simple on-ramp to software-defined infrastructure for Kubernetes deployments, delivering superior performance for latency-sensitive workloads ...

His case study on a Claudin 18.2-targeted therapy—now in global Phase III—highlighted China's evolving role from fast follower to protocol co-designer. Jacky Jiang, BD Head at CSPC Pharma ...